Literature DB >> 10689411

Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis.

D V Gopal1, H R Rosen.   

Abstract

Evaluating abnormal liver test results requires careful attention to the corresponding clinical data obtained during history taking and physical examination. Generally, it is helpful to separate liver tests into three categories: tests that assess synthetic function, tests that assess hepatocellular necrosis (hepatocellular enzymes), and tests that assess cholestasis. The clinical setting together with the specific pattern of liver function abnormalities can narrow differential diagnosis and provide a cost-effective approach to assessing patients and identifying those who need liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689411     DOI: 10.3810/pgm.2000.02.869

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  14 in total

Review 1.  Liver enzyme alteration: a guide for clinicians.

Authors:  Edoardo G Giannini; Roberto Testa; Vincenzo Savarino
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

2.  Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection.

Authors:  Nicola Coppola; Federica Portunato; Antonio Riccardo Buonomo; Laura Staiano; Riccardo Scotto; Biagio Pinchera; Stefania De Pascalis; Daniela Caterina Amoruso; Salvatore Martini; Mariantonietta Pisaturo; Carmine Coppola; Ivan Gentile
Journal:  J Nephrol       Date:  2019-04-11       Impact factor: 3.902

3.  Labour force participation among individuals with hepatitis C in the US.

Authors:  Philip Jacobs; Ying Chu Ng; Tania Stafinski; Roger Dodd; Bryce Larke; Winnie Wong
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity.

Authors:  Gabriela Villaça Chaves; Silvia Elaine Pereira; Carlos José Saboya; Andréa Ramalho
Journal:  Obes Surg       Date:  2008-02-09       Impact factor: 4.129

5.  The Relationships between Respiratory Virus Infection and Aminotransferase in Children.

Authors:  Jun Suk Oh; Jun Sik Choi; Young Hyuk Lee; Kyung Og Ko; Jae Woo Lim; Eun Jung Cheon; Gyung Min Lee; Jung Min Yoon
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-12-28

Review 6.  Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?

Authors:  Mazyar Malakouti; Archish Kataria; Sayed K Ali; Steven Schenker
Journal:  J Clin Transl Hepatol       Date:  2017-09-21

7.  The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease.

Authors:  John E Lewis; Steven E Atlas; Oscar L Higuera; Andrea Fiallo; Ammar Rasul; Ashar Farooqi; Olga Kromo; Laura A Lantigua; Eduard Tiozzo; Judi M Woolger; Sharon Goldberg; Armando Mendez; Allan E Rodriguez; Janet Konefal
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-03       Impact factor: 2.629

8.  Thymosin β4 Prevents Oxidative Stress, Inflammation, and Fibrosis in Ethanol- and LPS-Induced Liver Injury in Mice.

Authors:  Ruchi Shah; Karina Reyes-Gordillo; Ying Cheng; Ravi Varatharajalu; Joseph Ibrahim; M Raj Lakshman
Journal:  Oxid Med Cell Longev       Date:  2018-07-11       Impact factor: 6.543

9.  Comparison of postoperative liver function between different dissection techniques during laparoscopic cholecystectomy.

Authors:  Tagleb S Mazahreh; Abdelwahab J Aleshawi; Nabil A Al-Zoubi; Mohammad Altabari; Qusai Aljarrah
Journal:  Future Sci OA       Date:  2020-02-07

10.  Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.

Authors:  Shelli Schomaker; David Potter; Roscoe Warner; Jane Larkindale; Nicholas King; Amy C Porter; Jane Owens; Lindsay Tomlinson; John-Michael Sauer; Kent Johnson; Jiri Aubrecht
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.